Met Life Investment Management, LLC Collegium Pharmaceutical, Inc Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 19,987 shares of COLL stock, worth $568,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,987
Previous 18,429 8.45%
Holding current value
$568,430
Previous $712,000 19.66%
% of portfolio
0.0%
Previous 0.0%

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$28.61 - $41.86 $44,574 - $65,217
1,558 Added 8.45%
19,987 $572,000
Q2 2024

Aug 13, 2024
BUY
$31.36 - $39.99 $57,921 - $73,861
1,847 Added 11.14%
18,429 $593,000
Q1 2024

May 14, 2024
BUY
$31.23 - $40.91 $517,855 - $678,369
16,582 New
16,582 $643,000
Q2 2023

Apr 29, 2024
BUY
$21.06 - $24.0 $371,940 - $423,864
17,661 New
17,661 $379,000
Q2 2023

Aug 10, 2023
BUY
$21.06 - $24.0 $371,940 - $423,864
17,661 New
17,661 $379,000
Q1 2023

May 09, 2024
BUY
$23.0 - $29.88 $406,203 - $527,710
17,661 New
17,661 $424 Million
Q4 2022

May 10, 2024
SELL
$16.14 - $23.55 $43,190 - $63,019
-2,676 Reduced 13.16%
17,661 $409,000
Q4 2022

Jun 14, 2023
BUY
$16.14 - $23.55 $285,048 - $415,916
17,661 New
17,661 $409,000
Q4 2022

Mar 22, 2023
SELL
$16.14 - $23.55 $43,190 - $63,019
-2,676 Reduced 13.16%
17,661 $409,000
Q4 2022

Feb 15, 2023
SELL
$16.14 - $23.55 $43,190 - $63,019
-2,676 Reduced 13.16%
17,661 $409,000
Q3 2022

Jun 14, 2023
BUY
$15.46 - $20.1 $314,410 - $408,773
20,337 New
20,337 $325,000
Q2 2022

May 10, 2024
SELL
$14.22 - $20.88 $33,417 - $49,068
-2,350 Reduced 10.36%
20,337 $360,000
Q2 2022

Jun 20, 2023
BUY
$14.22 - $20.88 $289,192 - $424,636
20,337 New
20,337 $360,000
Q2 2022

Mar 22, 2023
SELL
$14.22 - $20.88 $33,417 - $49,068
-2,350 Reduced 10.36%
20,337 $360,000
Q2 2022

Aug 11, 2022
SELL
$14.22 - $20.88 $33,417 - $49,068
-2,350 Reduced 10.36%
20,337 $360,000
Q1 2022

May 10, 2024
BUY
$17.2 - $22.5 $390,216 - $510,457
22,687 New
22,687 $461,000
Q1 2022

Jun 20, 2023
BUY
$17.2 - $22.5 $390,216 - $510,457
22,687 New
22,687 $461,000
Q1 2022

Mar 22, 2023
BUY
$17.2 - $22.5 $148,866 - $194,737
8,655 Added 61.68%
22,687 $461,000
Q1 2022

May 12, 2022
BUY
$17.2 - $22.5 $148,866 - $194,737
8,655 Added 61.68%
22,687 $462,000
Q4 2021

Jun 21, 2023
BUY
$17.5 - $21.35 $245,560 - $299,583
14,032 New
14,032 $262,000
Q3 2021

Jun 21, 2023
BUY
$17.75 - $25.39 $249,068 - $356,272
14,032 New
14,032 $276,000
Q1 2021

May 17, 2024
SELL
$19.25 - $26.1 $49,087 - $66,555
-2,550 Reduced 15.38%
14,032 $332,000
Q1 2021

Jun 26, 2023
BUY
$19.25 - $26.1 $270,116 - $366,235
14,032 New
14,032 $333 Million
Q4 2020

Jun 22, 2023
BUY
$17.83 - $22.29 $250,190 - $312,773
14,032 New
14,032 $281,000
Q3 2020

Jun 26, 2023
BUY
$15.78 - $20.82 $221,424 - $292,146
14,032 New
14,032 $292,000
Q2 2020

May 24, 2024
SELL
$15.49 - $23.51 $39,499 - $59,950
-2,550 Reduced 15.38%
14,032 $246 Million
Q2 2020

Jun 26, 2023
BUY
$15.49 - $23.51 $217,355 - $329,892
14,032 New
14,032 $245,000
Q1 2020

Jul 12, 2023
BUY
$13.89 - $25.45 $194,904 - $357,114
14,032 New
14,032 $229,000
Q4 2019

Jul 12, 2023
BUY
$10.7 - $22.24 $150,142 - $312,071
14,032 New
14,032 $288,000
Q3 2019

Jul 12, 2023
BUY
$10.16 - $13.28 $142,565 - $186,344
14,032 New
14,032 $161,000
Q2 2019

Jul 12, 2023
BUY
$10.62 - $16.59 $149,019 - $232,790
14,032 New
14,032 $184,000
Q1 2019

Jul 13, 2023
BUY
$13.58 - $18.72 $190,554 - $262,679
14,032 New
14,032 $212,000
Q4 2018

Jul 13, 2023
BUY
$14.78 - $19.68 $207,392 - $276,149
14,032 New
14,032 $240,000
Q4 2018

Mar 22, 2023
SELL
$14.78 - $19.68 $132,340 - $176,214
-8,954 Reduced 38.95%
14,032 $240,000
Q4 2018

Feb 14, 2019
SELL
$14.78 - $19.68 $132,340 - $176,214
-8,954 Reduced 38.95%
14,032 $241,000
Q3 2018

Jul 13, 2023
BUY
$14.16 - $24.3 $198,693 - $340,977
14,032 New
14,032 $206,000
Q3 2018

Mar 22, 2023
BUY
$14.16 - $24.3 $75,402 - $129,397
5,325 Added 30.15%
22,986 $338,000
Q3 2018

Nov 14, 2018
BUY
$14.16 - $24.3 $325,481 - $558,559
22,986 New
22,986 $339,000

Others Institutions Holding COLL

# of Institutions
247
Shares Held
37.4M
Call Options Held
59.3K
Put Options Held
9.5K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $971M
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email